Integrating AI into the electronic medical record can make patient data more usable and dependable for end-users, according to a review of the relevant scientific literature published this month in the American Journal of Clinical and Medical Research.
The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%.
